Home › Free Stock Grades › MRVI
Maravai LifeSciences Holdings, Inc. (MRVI) Stock Grade
MRVI · Healthcare
C-
Market Cap
$2.1B
P/E Ratio
—
Revenue Growth (YoY)
-28.3%
Net Margin
-70.4%
Return on Equity
—
Dividend Yield
None
About Maravai LifeSciences Holdings, Inc.'s fundamentals
Maravai LifeSciences, a biotechnology company with a $2.1 billion market capitalization, is currently experiencing significant financial headwinds. Revenue declined 28.3% year-over-year, and the company reported a net loss with a net margin of -70.4%, indicating it spent substantially more than it earned. The company does not currently pay a dividend to shareholders. These metrics reflect a company in a challenging operational period, though context around the specific drivers of the revenue decline and any near-term path to profitability would be important for a complete understanding of the business.